Sponsored Helpline
Our Blog
Federal Plan Targets Mental Health Treatment Overprescribing
The U.S. Department of Health and Human Services announced Monday that it will work to reduce what officials call the overprescribing of psychiatric medications, with a particular focus on...
Written By: Courtney Myers
July 15, 2026
AI Speeds Up Drug Testing for Addiction Treatment
Written By: Peter Lee
July 15, 2026
AMA Notes Possible Cannabis Benefits for Seniors, With Caveats
Written By: Quentin Blount
July 14, 2026
Podcast: How Opioids Take Hold, and What Helps People Stay in Treatment
Written By: Dr. Sylvie Stacy
July 14, 2026
Patients Trust Addiction Treatment Staff With Lived Experience
Written By: Terri Beth Miller
July 14, 2026
All Posts
Federal Workplace Drug Testing Rules Affect Addiction Treatment
Workplace drug policy is entering one of its biggest shifts in years, and the...
Continue Reading
Low Confidence and Distorted Beliefs Limit Recovery, Study Finds
For anyone weighing addiction treatment, a new study offers a practical...
Continue Reading
Majority of 8th Graders Underestimate Fentanyl Risk, Research Finds
Many U.S. adolescents do not recognize how dangerous fentanyl is, and that...
Continue Reading
GLP-1 Drugs Draw New Attention for Senior Addiction Care
On July 1, 2026, Medicare launched a program that sharply lowered the price of...
Continue Reading
Study Links Parent Phone Use to Insecure Attachment in Children, Teens
Parents worried about screen time usually focus on their kids' devices. New...
Continue Reading
SAMHSA Opens $281 Million in Addiction Treatment Grants
Federal money is again moving toward addiction and mental health care, and the...
Continue Reading
Daily Fentanyl Use Equals Nearly 9,000 Morphine Milligrams, Study Finds
Anyone weighing addiction treatment for fentanyl, whether for themselves or a...
Continue Reading
Research Weighs In On Harm Reduction For Addiction Treatment
A federal announcement this month has reopened a long-running research question...
Continue Reading
Sewage Testing for Drugs Sparks Privacy Debate
The White House Office of National Drug Control Policy has endorsed a national...
Continue Reading